Does better adherence to prescribed treatment regimen reduce high chronic pain in adolescents and young adults with moderate or severe haemophilia?
Better adherence to prescribed treatment regimens is associated with significantly lower odds of experiencing high chronic pain in adolescents and young adults with moderate or severe haemophilia.
Little data exist, especially for adolescent and young adult (AYA) persons with haemophilia (PWH), about the relationship between adherence to prescribed treatment regimen and chronic pain. We examined this relationship among PWH (moderate or severe) aged 13-25 via cross-sectional survey. Adherence was assessed using the Validated Hemophilia Regimen Treatment Adherence Scale (VERITAS)-Pro and VERITAS-PRN for prophylactic and on-demand participants respectively. VERITAS scores range from 24 (most adherent) to 120 (least adherent). Chronic pain was measured using the FPS-R and was dichotomized as high for FPS-R scores ≥4 and low for 4 times as likely as whites to report high chronic pain.
McLaughlin et al. (Tue,) studied this question.